TMTilektes Maulenkul

Tilektes Maulenkul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tilektes Maulenkul has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Forecasting the future burden of major diseases in Kazakhstan using global burden of disease and time series models (ARIMA, Prophet, LSTM), 2019-2032

    by Tilektes Maulenkul, Temirgali Aimyshev, Ainash Oshibayeva, Adnan Yazici, Mohamad Aljofan, Aigerim Japparkulova, Abduzhappar Gaipov

    Background: Over the last years, it has become a widespread practice to use the global burden of disease (GBD) metrics for anticipating the disease patterns all over the world. Disability-adjusted life years (DALYs) is the main indicator to use for quantifying the losses in terms of health caused by disease. This study projects Kazakhstan’s disease burden from 2019 to 2032 by applying and comparing four forecasting approaches: GBD projections, auto-regressive integrated moving average (ARIMA), Prophet, and long short-term memory (LSTM) neural networks. Methods: DALY data for the top 10 disease categories in Kazakhstan were modeled using Python 3.11 with statistical and machine learning libraries. Each model was trained and validated for short- and medium-term forecasts, with performance compared across trajectory trends and disease ranking stability. Results: GBD and LSTM models projected stable rankings among the top 10 DALY contributors through 2032, with only malignant neoplasms of the colon and rectum showing a decline, while ARIMA and Prophet exhibited greater temporal fluctuations, predicting a drop in lower respiratory infections. Across all models, noncommunicable diseases, particularly, cardiovascular and metabolic disorders, remain dominant drivers of Kazakhstan’s future health burden. Conclusions: Deep learning (LSTM) and GBD approaches yielded smoother, more robust long-term predictions, whereas ARIMA and Prophet captured short-term variability more sensitively, highlighting the benefit of integrating statistical and AI-based paradigms for comprehensive national health forecasting and policy design.


  • Open Access

    Analysis of Hospital Admissions of Patients with Hyperthyroidism in Kazakhstan Based on Hospital Admissions Between 2013-2022 Years.

    by Tilektes Maulenkul

    Hyperthyroidism is a common endocrine disorder associated with significant cardiovascular, ophthalmological, and systemic complications if inadequately treated. While extensive epidemiological data are available from high-income countries, population-level evidence from Central Asia remains scarce. In Kazakhstan, thyroid disorders continue to represent a public health concern, and comprehensive national data on hyperthyroidism are limited. Objective: To describe the epidemiology, socio-demographic characteristics, clinical features, treatment patterns, complications, and mortality among patients diagnosed with hyperthyroidism in Kazakhstan. Methods. A retrospective population-based study was conducted using data from the Unified National Electronic Health System of Kazakhstan. Patients hospitalized with hyperthyroidism (ICD-10 code E05) between 2013 and 2022 were included. Demographic variables, regional distribution, ICD-10 subtypes, surgical and interventional treatments, complications, and mortality outcomes were analyzed. Descriptive statistics were used to summarize findings. Results. A total of 10,122 patients with hyperthyroidism were identified. Females predominated (72.2%), with the highest burden observed among individuals aged 18–70 years. Most patients were of Kazakh ethnicity (77.6%), and cases were nearly evenly distributed between urban and rural areas, with higher concentrations in Astana, Almaty, and East Kazakhstan regions. Graves’ disease (E05.0) accounted for approximately 80% of diagnoses. Total and subtotal thyroidectomy were the most common definitive treatments, together representing over 17% of cases. Cardiovascular (11.7%) and ophthalmological (6.5%) complications were most frequently observed. Overall mortality during the study period was 6.8%, with no significant sex-based differences. Conclusions. This study provides the first comprehensive national epidemiological assessment of hyperthyroidism in Kazakhstan. The findings highlight a substantial disease burden among women and working-age adults and underscore the importance of early diagnosis, optimized management strategies, and improved long-term follow-up to reduce complications and mortality.

  • Open Access

    Methodological Note on Predicting One-Year Mortality for Chronic Diseases Using Administrative Data

    by Iliyar Arupzhanov, Aidar Alimbayev, Temirlan Seyil, Temirgali Aimyshev, Tilektes Maulenkul, Ainash Oshibayeva, Abduzhappar Gaipov

    Chronic diseases remain a leading cause of global mortality, underscoring the need for developing reliable models that predict mortality prediction to guide individualized treatments and optimize resource allocation. This methodological note presents a reproducible framework for predicting one-year mortality in chronic disease patients using large-scale administrative healthcare data. The approach employs retrospective cohort design, year-specific subcohorts, and a stratified 5-fold cross-validation using a broad range of machine learning models. Performance is assessed with multiple metrics, including AUC, sensitivity, specificity, and balanced accuracy, to account for class imbalance. Model interpretability is enhanced through SHapley Additive exPlanations (SHAP), enabling identification of key mortality predictors and their directional impact. The proposed framework is general and can be applied to different chronic diseases. It has already been successfully demonstrated in nationwide cohorts of patients with diabetes mellitus and chronic viral hepatitis in Kazakhstan, achieving AUC values of 0.74–0.80, comparable to international benchmarks despite relying on administrative data alone. The method is scalable and adaptable, allowing integration of laboratory and clinical data with feature selection to address high-dimensionality challenges. Its generalizability and clinical relevance, however, should be validated in practice using enriched datasets across additional chronic diseases and diverse populations.


  • Open Access

    Comparative Analysis of Regional Mortality Rates and Causes in the Turkistan and Other Regions of Kazakhstan: Data from Unified National Electronic Healthcare System 2018-2023

    by Tilektes Maulenkul, Aizada Badiyeva, Temirgali Aimyshev, Makhsuda Abdussattarova, Aigerim Japparkulova, Gulnaz Nuskabayeva, Elmira Iskandirova, Ainash Oshibayeva, Abduzhappar Gaipov

    Background: Turkistan is the most densely populated region of Kazakhstan, with 75% of its population residing in rural areas. The region holds for a rich historical and cultural background as it was recently named as the spiritual capital of the Turkic world. Despite the importance of the place, it has its own challenges in the healthcare field, especially with mortality rates. This study aimed to discover and analyze the structure of the death rates in Turkistan region in order to provide a reliable data for future research projects. Methods: Mortality data were obtained from the Unified National Electronic Health System of Kazakhstan for 2018-2023 years. The dataset comprised 1,073,382 individual death records. The classification of causes of death followed the WHO Global Health Estimates methodology. All statistical analyses were performed using the Python 3.11. Results: Turkistan region had 632 deaths per 100,000 population, which was lower than the national average death rate in 2018, however, during the COVID pandemic the numbers spiked to 882 deaths per 100,000 population. Despite high numbers during COVID, the region has managed this problem and by 2023 remained in the top 3 regions with the lowest death rates. Additionally, the following diseases were identified as the leading causes of death by 2023: other neuropsychiatric disorders, cerebrovascular diseases, chronic obstructive pulmonary disease. Conclusion: Turkistan region needs to develop targeted health programs against the current top death causing diseases, with the emphasis on enhancing the diagnosis, treatment, coding and registration capabilities.

  • Open Access

    Impact of COVID-19 on Utilization of Healthcare Services Among People Living with HIV (PLHIV): A Systematic Review

    by Enyinnaya Ukaegbu, Tilektes Maulenkul, Antonio Sarria-Santamera

    Background and Objectives: People living with HIV/AIDS have been impacted notably by the COVID-19 pandemic in diverse dimensions. Although some impacts of COVID-19 on PLHIV have been well documented, there is still insufficient research that captures the overall understanding of the implications of COVID-19 for the healthcare utilization among PLHIV. This review aims to evaluate the impact of COVID-19 on PLHIV, narrowing it down to women living with HIV/AIDS. Materials and Methods: An electronic database search of primary studies that obtained information from health facility data regarding PLHIV since 2020 was carried out according to the PRISMA statement. A combination of search terms, e.g., “COVID-19 pandemic”, “SARS-CoV-2”, “Health services utilization”, “People living with Human immunodeficiency virus”, was included. Results: There was an overall decline in the utilization of health services such as medical consultations, ART uptake, and viral load monitoring by PLHIV at primary health centers at the forefront of care delivery. However, the countries in the sub-Saharan African region showed a progressive service increase over the pandemic. There was a scarcity of research on the impact of COVID-19 on women populations living with HIV/AIDS. Other methods of healthcare delivery such as telemedicine and postage services were instrumental to the delivery of HIV care services. Conclusions: The COVID-19 pandemic reduced the overall uptake of healthcare services among PLHIV and women living with HIV/AIDS. There is a need to boost research and strengthen health emergency preparedness for PLHIV, particularly women living with HIV/AIDS, during pandemics and further harness and maximize the use of contemporary healthcare delivery methods other than the traditional ones.


  • Open Access

    Double-negative T cells in pediatric rheumatic diseases

    by Dimitri Poddighe, Tilektes Maulenkul, Kuanysh Dossybayeva, Gulsamal Zhubanova, Zaure Mukusheva, Lyudmila Akhmaltdinova

    Double-negative (CD4-CD8-) T (DNT) cells have been implicated in autoimmune lymphoproliferative syndrome (ALPS), where their expansion inside the circulating pool of T cells represents a diagnostic criterion. Recent experimental evidence has supported the immunomodulatory roles of DNT cells, and studies in adult patients have suggested that they may be altered in some immune-mediated conditions. This study aimed to retrieve available data on circulating DNT cells in pediatric rheumatic disorders that do not arise in the context of ALPS through a systematic literature review of 3 scientific databases (PubMed, Scopus, and Web of Science). The final output of the systematic literature search consisted of 8 manuscripts, including cross-sectional (n=6) and longitudinal (n=2) studies. Overall, the pooled population of patients includes children affected with pediatric systemic lupus erythematosus (n= 104), juvenile idiopathic arthritis (n=92), Behçet's disease (n=15), mixed connective tissue disease (n=8), juvenile dermatomyositis (n=6), and Kawasaki disease/multisystem inflammatory disease in children (n=1 and n=14, respectively); moreover, one study also included 11 children with a high titer of antinuclear antibody but no diagnosis of rheumatic disease. All studies except one included a control group. The number of DNT cells were increased in most studies of children with rheumatic diseases. Even if such a limited number of studies and their great heterogeneity in several methodological aspects do not allow for reliable conclusions about the relevance of DNT cells in specific rheumatic conditions in children, this cell population deserves further investigation in this pathological setting through well-designed clinical studies.


  • Open Access

    Natural Killer T (NKT) Cells in Autoimmune Hepatitis: Current Evidence from Basic and Clinical Research.

    by Dimitri Poddighe, Tilektes Maulenkul, Gulsamal Zhubanova, Lyudmila Akhmaldtinova, Kuanysh Dossybayeva

    Natural killer T (NKT) cells are unconventional T cells that are activated by glycolipid antigens. They can produce a variety of inflammatory and regulatory cytokines and, therefore, modulate multiple aspects of the immune response in different pathological settings, including autoimmunity. NKT cells have also been implicated in the immunopathogenesis of autoimmune hepatitis, and in this review we summarize and analyze the main studies investigating the involvement and/or homeostasis of NKT cells in this disease. In detail, the evidence from both basic and clinical research has been specifically analyzed. Even though the experimental murine models supported a relevant role of NKT cells in immune-mediated hepatic injury, very few studies specifically investigated NKT cell homeostasis in patients with autoimmune hepatitis; however, these initial studies reported some alterations of NKT cells in these patients, which may also correlate with the disease activity to some extent. Further clinical studies are needed to investigate the potential role and use of NKT cell analysis as a disease marker of clinical relevance, and to better understand the precise cellular and molecular mechanisms by which NKT cells contribute to the pathogenesis of autoimmune hepatitis.


  • Open Access

    The rate of medication nonadherence and influencing factors: A systematic Review

    by Mohamad Aljofan, Ainash Oshibayeva, Ikilas Moldaliyev, Yerbolat Saruarov, Tilektes Maulenkul, Abduzhappar Gaipov

    Lack of adherence to recommended therapy will reduce its effectiveness and can subsequently lead to disease progression, disabilities or even death. A vast number of research studies have emphasized the magnitude of medication nonadherence and its effect on treatment outcomes, patient’s health, healthcare providers and the associated costs; medication nonadherence remains a major concern that is believed to be widely practiced amongst medication taking patients. The current systemic review aims to cohere the available evidence regarding medication nonadherence rate, practices, and potential affecting factors and predictors. A search through different databases was conducted, including PubMed, Medline, and CINHAL for recently published research articles, within five years. The terms used for the search include medication nonadherence, medication nonadherence, factors affecting medication nonadherence and predictors of medication nonadherence. The search was limited to human subjects, English language journal articles and exclusion of review articles, case studies, and data from clinical trials as patient adherence is closely observed. The search resulted in 667 articles and only 65 articles were included and further screened. However, according to our exclusion criteria, 15 articles only were included in this review. The three most reported practices of medication nonadherence are prescription abandonment, nonconforming, and non-persistence. There are five reported factors that may lead to nonadherence practices such as socioeconomic-related factors, healthcare system-related factors, patient-related factors, disease-related factors, and therapy-related factors. In conclusion, medication nonadherence practice is a multi-dimensional phenomenon that requires a multi-targeted solution.


  • Open Access

    Population Health and Health Services: Old Challenges and New Realities in the COVID-19 Era

    by Antonio Sarría-Santamera, Alua Yeskendir, Tilektes Maulenkul, Binur Orazumbekova, Abduzhappar Gaipov, Iñaki Imaz-Iglesia, Lorena Pinilla-Navas, Teresa Moreno-Casbas, Teresa Corral

    (1) Background: Health services that were already under pressure before the COVID-19 pandemic to maximize its impact on population health, have not only the imperative to remain resilient and sustainable and be prepared for future waves of the virus, but to take advantage of the learnings from the pandemic to re-configure and support the greatest possible improvements. (2) Methods: A review of articles published by the Special Issue on Population Health and Health Services to identify main drivers for improving the contribution of health services on population health is conducted. (3) Health services have to focus not just on providing the best care to health problems but to improve its focus on health promotion and disease prevention. (4) Conclusions: Implementing innovative but complex solutions to address the problems can hardly be achieved without a multilevel and multisectoral deliberative debate. The CHRODIS PLUS policy dialog method can help standardize policy-making procedures and improve network governance, offering a proven method to strengthen the impact of health services on population health, which in the post-COVID era is more necessary than ever.


  • Open Access

    The Identification of Diabetes Mellitus Subtypes Applying Cluster Analysis Techniques: A Systematic Review

    by Antonio Sarría-Santamera, Binur Orazumbekova, Tilektes Maulenkul, Abduzhappar Gaipov, Kuralay Atageldiyeva

    Diabetes Mellitus is a chronic and lifelong disease that incurs a huge burden to healthcare systems. Its prevalence is on the rise worldwide. Diabetes is more complex than the classification of Type 1 and 2 may suggest. The purpose of this systematic review was to identify the research studies that tried to find new sub-groups of diabetes patients by using unsupervised learning methods. The search was conducted on Pubmed and Medline databases by two independent researchers. All time publications on cluster analysis of diabetes patients were selected and analysed. Among fourteen studies that were included in the final review, five studies found five identical clusters: Severe Autoimmune Diabetes; Severe Insulin-Deficient Diabetes; Severe Insulin-Resistant Diabetes; Mild Obesity-Related Diabetes; and Mild Age-Related Diabetes. In addition, two studies found the same clusters, except Severe Autoimmune Diabetes cluster. Results of other studies differed from one to another and were less consistent. Cluster analysis enabled finding non-classic heterogeneity in diabetes, but there is still a necessity to explore and validate the capabilities of cluster analysis in more diverse and wider populations.